Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-14-000305
Filing Date
2014-11-05
Accepted
2014-11-05 12:38:47
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tlog-20140930x10q.htm 10-Q 1253595
2 EX-31.1 tlog-20140930ex311455405.htm EX-31.1 19740
3 EX-31.2 tlog-20140930ex312291987.htm EX-31.2 19528
4 EX-32.1 tlog-20140930ex321dea0a4.htm EX-32.1 9397
5 EX-32.2 tlog-20140930ex3226eed84.htm EX-32.2 8991
  Complete submission text file 0001558370-14-000305.txt   7703193

Data Files

Seq Description Document Type Size
6 EX-101.INS tlog-20140930.xml EX-101.INS 1354551
7 EX-101.SCH tlog-20140930.xsd EX-101.SCH 35104
8 EX-101.CAL tlog-20140930_cal.xml EX-101.CAL 59706
9 EX-101.DEF tlog-20140930_def.xml EX-101.DEF 126981
10 EX-101.LAB tlog-20140930_lab.xml EX-101.LAB 385105
11 EX-101.PRE tlog-20140930_pre.xml EX-101.PRE 251306
Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Filer) CIK: 0001361248 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36208 | Film No.: 141196037
SIC: 2834 Pharmaceutical Preparations